Dispensed: Huge Pharma’s plans to take on buzzy start-ups, Sanofi’s entrance to the coronavirus vaccine race, and a Medicare Benefit pitch deck
Welcome to Given, Company Insider’s weekly healthcare newsletter. This week’s edition is being composed in sunny Palm Springs, California, though unfortunately sent back in cold New York.
The huge story I wish to highlight today originated from a tag-team in between Andrew Dunn and me
We got the scoop on Dermatology.com, the website pharmaceutical business Bausch Health (keep in mind Valeant Pharmaceuticals?) is utilizing to participate the pattern of start-ups that are prescribing and shipping medication directly to your door.
Since I first began becoming aware of companies like Roman, Hims, or Nurx, I have actually been thinking it ‘d just refer time prior to drugmakers themselves see this as a brand-new way to reach clients. And when they do get interested, who are the business they’ll need to work with to pull that off?
What Bausch is finishing with its dermatology drugs provides us an excellent idea of what we might anticipate.
Big Pharma simply started copying the buzzy startups that ship Viagra and hair-loss tablets to your door, and it could be the start of a ‘mega-trend’
- The pharmaceutical company Bausch Health is now selling prescription drugs online to deal with conditions like acne, wrinkles, and eczema.
- The $9 billion drugmaker is following a method comparable to buzzy start-ups like Roman and Hims, which utilize online physician visits to prescribe Viagra and hair-loss pills online.
- ” I think that we lead a mega-trend here,” Costs Humphries, president of Bausch’s Ortho Dermatologics service, told Business Expert.
- Dermatology.com is tapping the healthcare innovation startup RxDefine to help with virtual check outs with doctor.
Have not leapt on the BI Prime wagon? You can use my link here to get 20% off your BI Prime membership.
Previously in the week, I got my hands on the pitch deck Troy Medicare’s utilizing to raise its series B. As more business want to jump into the Medicare Advantage market, it was interesting to get a look at the start-up’s pharmacy-specific method.
We got a take a look at the slide deck a medical insurance start-up is using to raise $25 million for its bet that pharmacists can help it take on the red-hot Medicare Advantage market
Continuing my deep-dive into the financials of medical care companies, I spoke with the team at Privia Health about its technique to taking the primary care company national.
Here’s an unique look at the financials of Privia, an under-the-radar upstart taking on the primary care industry
As a pointer: Want to talk financials? Program me your pitch deck? I’m all ears! You can find me at [email protected]
Andrew spent a long time up at Intercept Pharmaceuticals’ Hudson Yards offices here in New York. There, he talked with CEO Mark Pruzanski about what’s ahead, ought to the business become the first drugmaker with an authorized treatment for NASH, a liver condition that impacts millions of Americans.
How a $3 billion biotech got away a ‘graveyard of failures’ in the race to release the first-ever drug for a silent illness that strikes millions
Come for the origins of Intercept, stay for Andrew’s comprehensive analysis of the tough-to-crack market and why Pruzanski thinks he can turn Intercept’s NASH drug into a smash hit.
Andrew likewise has the latest on the race to establish a vaccine for the novel coronavirus On Tuesday, Sanofi jumped in the fray also.
Here’s a better look at the pharma giant’s approach.
Pharma giant Sanofi is developing a vaccine to combat the lethal coronavirus outbreak utilizing its previous research on SARS
I also wished to highlight a story from our marijuana fellow, Yeji Lee She took a close look at a CBN, or cannabinol, the current cannabis substance companies are pitching to attempt and split into the health industry.
The twist: CBN today is 7X more pricey than CBD.
There’s a hot brand-new cannabis substance that declares it’ll assist you sleep much better. Meet CBN, which is chasing after a $1 billion-plus market.
With that, I’ll leave you to your weekends. I’m gone out to Colorado this weekend to see some snow and get some snowboarding in. Next week, you can eagerly anticipate Andrew’s launching Dispensed striking your inbox.